Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has shared an announcement.
Jubilant Pharmova Limited has launched an initiative as part of the ‘Saksham Niveshak – 100 Days Campaign’ to assist shareholders in updating their KYC details and claiming unpaid dividends. This campaign, directed by the Ministry of Corporate Affairs, aims to prevent the transfer of unclaimed dividends and shares to the Investor Education and Protection Fund Authority, ensuring shareholders secure their entitlements.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is involved in providing healthcare solutions and has a market presence in various regions.
Average Trading Volume: 11,133
Technical Sentiment Signal: Buy
Current Market Cap: 175.2B INR
Learn more about JUBLPHARMA stock on TipRanks’ Stock Analysis page.